Trial Profile
Phase 3 Multicenter Randomized Double-Blind, Double-dummy, Active-Controlled Study Comparing Efficacy/Safety of Gastric-retentive, Controlled-release Accordion Pill Carbidopa/Levodopa to Immediate Release in Fluctuating Parkinson's Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2020
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Acronyms Accordance
- Sponsors Intec Pharma
- 05 Aug 2020 Status changed from active, no longer recruiting to completed, according to an Intec Pharma media release.
- 05 Dec 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 26 Sep 2019 Trial design presented at the 23rd International Congress of Parkinson's Disease and Movement Disorders